Under terms of a recently signed agreement, the institutions will jointly undertake research in several areas including nano-medicine, nano-bio materials, smart orthopaedic implants, biomolecular imaging, biocomputation and bioinformatics, bio-MEMS and the development of drug delivery devices.
"This collaboration will accelerate scientific progress by bringing together the strengths of the Rensselaer Polytechnic Institute, a top-notch engineering and basic science university, with the translational biomedical research expertise in the Clinic's Lerner Research Institute," said Paul DiCorleto, Ph.D., Chairman of the Lerner Research Institute. "These two institutions are highly complementary and multiple areas for collaboration have been identified."
Together the Lerner Research Institute and Rensselaer Polytechnic Institute will develop joint research proposals and secure funding from federal and non-federal funding sources, such as corporations, foundations and private philanthropists.
The collaborating institutions will also establish a visiting scientist program and a summer internship program for undergraduate and graduate students. In addition, the Lerner Research Institute and Rensselaer Polytechnic Institute plan to hold joint research retreats, fund a joint seed grant program, offer joint seminars and workshops, and facilitate joint proposals and briefings to the National Institutes of Health in areas of mutual interest.
"As part of the Rensselaer Plan, we have made substantial strategic investments in bioscience, bioengineering, nanotechnology and information technology," said Omkaram "Om" Nalamasu, Ph.D., Vice President of Research at Rensselaer Polytechnic Institute. "Combining the
Contact: Tiffany Lohwater
Rensselaer Polytechnic Institute